{"organizations": [], "uuid": "1982526480a1b2e4231c7d131de42b9f6872818e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XB297_EMFLAZ_SOC_20180118113643.jpg", "site_section": "http://www.wsj.com/xml/rss/3_7014.xml", "section_title": "WSJ.com: US Business", "url": "https://www.wsj.com/articles/drugmaker-raises-u-s-price-of-muscular-dystrophy-treatment-1516295645", "country": "US", "domain_rank": 387, "title": "Drugmaker Raises U.S. Price of Muscular-Dystrophy Treatment", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-18T19:14:00.000+02:00", "replies_count": 0, "uuid": "1982526480a1b2e4231c7d131de42b9f6872818e"}, "author": "Joseph Walker", "url": "https://www.wsj.com/articles/drugmaker-raises-u-s-price-of-muscular-dystrophy-treatment-1516295645", "ord_in_thread": 0, "title": "Drugmaker Raises U.S. Price of Muscular-Dystrophy Treatment", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "europe", "sentiment": "none"}], "organizations": [{"name": "u.s. price of muscular-dystrophy treatment ptc therapeutics inc.", "sentiment": "negative"}, {"name": "food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "PTC Therapeutics Inc. this month increased the list price of its muscular-dystrophy treatment by about 9%, to more than $65,000 annually for a common dosage.\n\nThe price increase again puts a spotlight on Emflaza, a decades-old steroidal drug that many U.S. patients had been paying $1,200 or less annually to import from Europe before the Food and Drug Administration last year approved the drug for U.S. sale as a treatment for Duchenne muscular dystrophy. The rare genetic disease affects up to 12,000 Americans, most of whom...  ", "external_links": [], "published": "2018-01-18T19:14:00.000+02:00", "crawled": "2018-01-18T21:38:59.007+02:00", "highlightTitle": ""}